CVie Therapeutics Company Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $67.5M

  • Investors
  • 1

CVie Therapeutics Company General Information

Description

Developer of drugs designed to treat cardiovascular diseases. The company's drugs treats hypertension and acute heart failure, enabling customers to get drugs that target the unmet medical needs.

Contact Information

Formerly Known As
Zhongsheng International Co., Ltd., CVie International Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11F., No.36, Songren Rd.
  • Xinyi District
  • Taipei, 110-73
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 11F., No.36, Songren Rd.
  • Xinyi District
  • Taipei, 110-73
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CVie Therapeutics Company Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 21-Dec-2018 $67.5M Completed Generating Revenue
4. Early Stage VC (Series B) 13-Aug-2013 Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Early Stage VC (Series A) 07-Aug-2012 $6M $6M Completed Generating Revenue
1. Joint Venture 07-Aug-2012 Completed Generating Revenue
To view CVie Therapeutics Company’s complete valuation and funding history, request access »

CVie Therapeutics Company Patents

CVie Therapeutics Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12503484-B2 Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure Active 09-Oct-2019
US-20230009312-A1 Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure. Active 09-Oct-2019
JP-2021532190-A 17 beta-heterocyclic digitalis analogs for the treatment of heart failure Active 26-Jul-2018
JP-7421815-B2 17beta-heterocyclic digitalis analogs for the treatment of heart failure Active 26-Jul-2018
AU-2019312478-A1 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure Active 26-Jul-2018 A61K31/58
To view CVie Therapeutics Company’s complete patent history, request access »

CVie Therapeutics Company Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDIB Capital Group Asset Manager Minority
China Cardiovascular Focus Corporation Minority
Ivy Blue Holdings Venture Capital Minority
Kleiner Perkins Venture Capital Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

CVie Therapeutics Company FAQs

  • When was CVie Therapeutics Company founded?

    CVie Therapeutics Company was founded in 2012.

  • Where is CVie Therapeutics Company headquartered?

    CVie Therapeutics Company is headquartered in Taipei, Taiwan.

  • What industry is CVie Therapeutics Company in?

    CVie Therapeutics Company’s primary industry is Drug Discovery.

  • Is CVie Therapeutics Company a private or public company?

    CVie Therapeutics Company is a Private company.

  • What is the current valuation of CVie Therapeutics Company?

    The current valuation of CVie Therapeutics Company is .

  • What is CVie Therapeutics Company’s current revenue?

    The current revenue for CVie Therapeutics Company is .

  • How much funding has CVie Therapeutics Company raised over time?

    CVie Therapeutics Company has raised $16M.

  • Who are CVie Therapeutics Company’s investors?

    CDIB Capital Group, China Cardiovascular Focus, Ivy Blue Holdings, Kleiner Perkins, and LAV (Lilly Asia Fund) are 5 of 6 investors who have invested in CVie Therapeutics Company.

  • When was CVie Therapeutics Company acquired?

    CVie Therapeutics Company was acquired on 21-Dec-2018.

  • Who acquired CVie Therapeutics Company?

    CVie Therapeutics Company was acquired by Windtree Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process